We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
Cap. Flow
+$169M
Cap. Flow %
0.95%
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160

Sector Composition

Rank Sector Weight
1 Technology 8.86%
2 Financials 4.76%
3 Consumer Discretionary 4.5%
4 Healthcare 4.18%
5 Consumer Staples 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLX icon
2526
VanEck Steel ETF
SLX
$174M
$247K ﹤0.01%
5,167
+510
+11% +$26.4K
UDR icon
2527
UDR
UDR
$12.1B
$247K ﹤0.01%
5,924
+1,211
+26% +$55.6K
DTP
2528
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$247K ﹤0.01%
4,921
-14,710
-75% -$754K
BRC icon
2529
Brady Corp
BRC
$4.44B
$246K ﹤0.01%
5,907
+55
+0.9% +$2.54K
CTO
2530
CTO Realty Growth
CTO
$823M
$246K ﹤0.01%
13,108
+205
+2% +$4.28K
GALT icon
2531
Galectin Therapeutics
GALT
$341M
$246K ﹤0.01%
150,661
+1,922
+1% +$3.59K
VIAV icon
2532
Viavi Solutions
VIAV
$10.6B
$246K ﹤0.01%
18,837
GBT
2533
DELISTED
Global Blood Therapeutics, Inc.
GBT
$246K ﹤0.01%
+3,615
New +$199K
ACRS icon
2534
Aclaris Therapeutics
ACRS
$888M
$245K ﹤0.01%
15,538
+200
+1% +$3.15K
ALE
2535
DELISTED
Allete
ALE
$245K ﹤0.01%
4,888
-195
-4% -$11.6K
AMN icon
2536
AMN Healthcare
AMN
$1.3B
$245K ﹤0.01%
2,315
+253
+12% +$27.7K
IMKTA icon
2537
Ingles Markets
IMKTA
$1.68B
$245K ﹤0.01%
3,090
+111
+4% +$10.1K
JMEE icon
2538
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.97B
$245K ﹤0.01%
5,524
+664
+14% +$32.4K
ROUS icon
2539
Hartford Multifactor US Equity ETF
ROUS
$732M
$245K ﹤0.01%
6,950
-61
-0.9% -$2.37K
NEE.PRP
2540
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$245K ﹤0.01%
4,917
ALLE icon
2541
Allegion
ALLE
$14B
$244K ﹤0.01%
2,721
-52
-2% -$5.15K
FLV icon
2542
American Century Focused Large Cap Value ETF
FLV
$377M
$244K ﹤0.01%
4,606
-130
-3% -$7.47K
GBDC icon
2543
Golub Capital BDC
GBDC
$3.47B
$244K ﹤0.01%
19,704
+5,058
+35% +$68.8K
QLTA icon
2544
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.22B
$244K ﹤0.01%
5,372
+758
+16% +$36.6K
SIZE icon
2545
iShares MSCI USA Size Factor ETF
SIZE
$447M
$244K ﹤0.01%
2,341
-157
-6% -$18.2K
DNL icon
2546
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$506M
$243K ﹤0.01%
8,847
+1,396
+19% +$43.9K
ERH
2547
Allspring Utilities & High Income Fund
ERH
$103M
$243K ﹤0.01%
22,171
+406
+2% +$5K
FVRR icon
2548
Fiverr
FVRR
$316M
$243K ﹤0.01%
7,939
-772
-9% -$27.4K
NKX icon
2549
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$665M
$243K ﹤0.01%
20,555
+98
+0.5% +$1.3K
PRI icon
2550
Primerica
PRI
$9.61B
$243K ﹤0.01%
+1,970
New +$250K

Similar funds

Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
  • Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
  • Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
  • Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.